Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2009 1
2010 1
2012 1
2014 2
2015 3
2016 3
2017 5
2018 5
2019 4
2020 4
2021 9
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.
Marques Da Costa ME, Zaidi S, Scoazec JY, Droit R, Lim WC, Marchais A, Salmon J, Cherkaoui S, Morscher RJ, Laurent A, Malinge S, Mercher T, Tabone-Eglinger S, Goddard I, Pflumio F, Calvo J, Redini F, Entz-Werlé N, Soriano A, Villanueva A, Cairo S, Chastagner P, Moro M, Owens C, Casanova M, Hladun-Alvaro R, Berlanga P, Daudigeos-Dubus E, Dessen P, Zitvogel L, Lacroix L, Pierron G, Delattre O, Schleiermacher G, Surdez D, Geoerger B. Marques Da Costa ME, et al. Among authors: moro m. Commun Biol. 2023 Sep 18;6(1):949. doi: 10.1038/s42003-023-05320-0. Commun Biol. 2023. PMID: 37723198 Free PMC article.
Therapeutic use of microRNAs in lung cancer.
Fortunato O, Boeri M, Verri C, Moro M, Sozzi G. Fortunato O, et al. Among authors: moro m. Biomed Res Int. 2014;2014:756975. doi: 10.1155/2014/756975. Epub 2014 Sep 16. Biomed Res Int. 2014. PMID: 25309923 Free PMC article. Review.
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.
Ndembe G, Intini I, Moro M, Grasselli C, Panfili A, Panini N, Bleve A, Occhipinti M, Borzi C, Garassino MC, Marabese M, Canesi S, Scanziani E, Sozzi G, Broggini M, Ganzinelli M. Ndembe G, et al. Among authors: moro m. J Exp Clin Cancer Res. 2024 Jan 2;43(1):6. doi: 10.1186/s13046-023-02933-5. J Exp Clin Cancer Res. 2024. PMID: 38163906 Free PMC article.
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells.
Parodi M, Centonze G, Murianni F, Orecchia P, Andriani F, Roato I, Gardelli C, Balsamo M, Moro M, Taiè G, Pastorino U, Petretto A, Lavarello C, Milione M, Sozzi G, Roz L, Vitale M, Bertolini G. Parodi M, et al. Among authors: moro m. J Immunother Cancer. 2024 Mar 7;12(3):e007895. doi: 10.1136/jitc-2023-007895. J Immunother Cancer. 2024. PMID: 38458638 Free PMC article.
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway.
Moro M, Fortunato O, Bertolini G, Mensah M, Borzi C, Centonze G, Andriani F, Di Paolo D, Perri P, Ponzoni M, Pastorino U, Sozzi G, Boeri M. Moro M, et al. Pharmaceuticals (Basel). 2022 Feb 28;15(3):297. doi: 10.3390/ph15030297. Pharmaceuticals (Basel). 2022. PMID: 35337095 Free PMC article.
43 results